证券代码：603312 证券简称：西典新能 苏州西典新能源电气股份有限公司 会议资料 苏州西典新能源电气股份有限公司 2025 年第三次临时股东会会议资料 目 录 苏州西典新能源电气股份有限公司 为维护全体股东的合法权益，确保苏州西典新能源电气股份有限公司（以下 简称"公司"）本次股东会会议秩序和议事效率，根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《上市公司股东会规则》以及《公司章程》和《股 东会议事规则》的有关规定，特制定股东会须知如下： 一、公司董事会以维护全体股东的合法权益、维持会议正常秩序和提高议事 效率为原则，认真履行《公司章程》等规定的职责，做好召集、召开股东会的各 项工作。公司董事会办公室具体负责股东会会务工作，出席会议人员应当听从会 务工作人员安排，共同维护好会议秩序。 二、为保证股东会的正常进行，除出席会议的股东或者股东代理人、董事、 高级管理人员、董事会秘书、见证律师、本次会议议程有关人员及会务工作人员 以外，公司有权拒绝其他人员进入会场。股东进入会场后，请自觉关闭手机或调 至振动状态。谢绝个人录音、拍照及录像。请勿在会场内大声喧哗。对于干扰会 议秩序、寻衅滋事和侵犯股东合 ...

证券代码：603456 证券简称：九洲药业 公告编号：2025-050 重要内容提示： ? 增资标的名称：九洲药业（台州）有限公司（原名"瑞博（台州）制药 有限公司"，以下简称"九洲药业（台州）"） ? 增资金额：浙江九洲药业股份有限公司（以下简称"公司"）以募集资金 期工程）"实施主体九洲药业（台州）进行增资。本次增资事项已经公司第八届 董事会第十六次会议和第八届监事会第十次会议审议通过，无需提交股东大会审 议。 ? 本次增资对本公司财务状况和经营成果无不利影响。 公司于 2025 年 8 月 5 日召开第八届董事会第十六次会议和第八届监事会第 十次会议，审议通过了《关于使用部分募集资金向募投项目实施主体增资实施募 投项目的议案》，现将有关情况披露如下： 一、募集资金基本情况 经中国证券监督管理委员会（以下简称"中国证监会"） 《关于核准浙江九洲 浙江九洲药业股份有限公司 关于使用部分募集资金向募投项目实施主体增资 实施募投项目的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、募集资金投资项目情况 本次非公开发行股 ...

Core Viewpoint - The company, Zhongke Hanwuji Technology Co., Ltd., held its 24th meeting of the second Supervisory Board on July 17, 2025, where several key resolutions were passed regarding the use of raised funds and adjustments to the stock issuance plan [1][2]. Group 1: Fund Utilization - The Supervisory Board approved the use of 100 million RMB of raised funds to increase the capital of its wholly-owned subsidiary, Shanghai Hanwuji Information Technology Co., Ltd., to support the implementation of financing projects [1][2]. - The board also agreed to allow the company and its subsidiary to use their own funds to pay for project expenses, which will later be replaced with an equivalent amount from the raised funds [2][3]. Group 2: Stock Issuance Adjustments - The board approved adjustments to the 2025 stock issuance plan, allowing the number of shares issued to be determined by the total amount raised divided by the issuance price, with a cap of 5% of the total share capital prior to the issuance [3][6]. - The maximum number of shares to be issued was adjusted from 20,872,837 shares to 20,917,511 shares due to an increase in total share capital following the completion of a stock incentive plan [3][4]. Group 3: Financial Projections - The total amount to be raised from the stock issuance was revised from a maximum of 4,980 million RMB to 3,985.3273 million RMB, with the net amount after deducting issuance costs intended for various projects [5][6]. - The company confirmed that the other parts of the stock issuance plan remain unchanged despite these adjustments [5][6]. Group 4: Reports and Analysis - The board approved several reports related to the revised stock issuance plan, including feasibility analysis and measures to address the dilution of immediate returns [7][8][9]. - The company also confirmed that the raised funds will be directed towards technology innovation, aligning with its strategic goals [9][10].

Group 1 - The company plans to use raised funds to increase capital for its subsidiary Henan Yuzhan by 725.65 million yuan, which will then be used to increase capital for Shenzhen Yuzhan by the same amount [1] - The purpose of this capital increase is to ensure the smooth implementation of fundraising projects, enhance the capital strength of the project implementation entity, and improve the efficiency of fund utilization [1] - This capital increase does not constitute a related party transaction or a major asset restructuring, and does not require approval from the shareholders' meeting [1]